BPC
ABBV icon

Bearing Point Capital’s AbbVie ABBV Stock Holding History

Bearing Point Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.72M Buy
14,798
+136
+0.9% +$29.3K 0.5% 63
2026
Q1 		$3.19M Buy
14,662
+110
+0.8% +$24.4K 0.5% 62
2025
Q4 		$3.32M Buy
14,552
+306
+2% +$69.7K 0.52% 62
2025
Q3 		$3.3M Sell
14,246
-1,216
-8% -$248K 0.57% 58
2025
Q2 		$2.87M Buy
15,462
+352
+2% +$65.4K 0.53% 60
2025
Q1 		$3.17M Sell
15,110
-944
-6% -$184K 0.67% 55
2024
Q4 		$2.85M Buy
+16,054
New +$2.95M 0.59% 53

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bearing Point Capital's ABBV Position: Q2 2026 in Review

Bearing Point Capital increased its AbbVie (ABBV) stake by 0.93% in Q2 2026, buying an estimated $29.3K and bringing the position to 14,798 shares worth $3.72M. The position accounts for 0.5% of the portfolio, ranked #63.

Bearing Point Capital first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Bearing Point Capital held 14,798 shares of AbbVie worth $3.72M as of Q2 2026.
  • Bearing Point Capital bought 136 AbbVie shares in Q2 2026, an estimated $29.3K.
  • AbbVie made up 0.5% of Bearing Point Capital's portfolio in Q2 2026, its #63 holding.
  • Bearing Point Capital first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bearing Point Capital's 13F filing for Q2 2026, filed 11 Aug 2026.